Signaling Pathways in Cancer 2013: Targeting the HER/EGFR family: Focus on breast, lung and colorectal cancers, March 1 - 2 2013, Sitges, Spain
ESMO aims to implement a series of symposia on signalling pathways for academic clinical researchers and industry researchers. The first of such symposia will focus on the HER family of receptors across lung, breast and colorectal cancers. Read more here.
No comments:
Post a Comment